A UBC and BC Cancer-led team has received more than $23 million in federal funding to develop precision radiopharmaceuticals that promise to transform cancer treatment Radiation has been a staple… Read More
A new drug candidate for autoimmune disease VANCOUVER, BC — Novateur Ventures, a global life sciences advisory firm, is pleased to announce that our client Daewoong Pharmaceutical, a leading South… Read More
VANCOUVER, BC — Sonic Incytes is pleased to announce they have received Food and Drug Administration (FDA) clearance for new Organ Guide and Wave Quality Detector features for Velacur™, the… Read More
A UBC-led team has received more than $23 million in federal funding to develop precision radiopharmaceuticals that promise to transform cancer treatment in Canada and beyond. Radiation has been a… Read More
This is the eighth indication for DUPIXENT® in Canada and its first in gastroenterology. MISSISSAUGA, ON — /CNW/ — sanofi-aventis Canada Inc. (Sanofi Canada) is pleased to announce that Health Canada has issued a… Read More
